Ibrutinib
(asked on 5th June 2018) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care how many people have received Ibrutinib on the NHS for the treatment of relapsed or refractory chronic lymphocytic leukaemia since January 2017.
This question was answered on 13th June 2018
The information requested is not available. The number of patients registered to receive treatment with ibrutinib for relapsed or refractory chronic lymphocytic leukaemia between 1 January 2017 and 31 May 2018 was 976. Patients registered to receive a treatment do not then necessarily go on to receive treatment with a drug.